Nonobstructive CAD: Recognition needed, treatment options sought
Outpatient CVD care delivery similar between physician, nonphysician primary care providers
Lipid Forum II Highlights
Antiplatelet Therapy in ACS and PCI
Study findings of long-term outcomes in adults with hypertrophic cardiomyopathy found that disease-related mortality rates have dropped to approximately 0.5% per year due to advances in management of and treatments for the condition.
Adult-onset hypertrophic cardiomyopathy has traditionally been associated with annual mortality rates of up to 6% due to complications, including sudden death and death from HF, according to the study background.
This activity is supported by an educational grant from Daiichi Sankyo, Inc. and Lilly USA, LLC.
This activity is supported by an educational grant from AstraZeneca.
The role of lipid-lowering therapies: A look at the guidelines
Nathaniel Reichek, MD: A pioneer in the development of cardiac MRI
This feature offers timely executive summaries of the most relevant journals in cardiology.
Snapshot summaries of recent study results in cardiology.
Your central portal for information presented at ACC 2015.
Your resource for news and videos from SCAI 2014.
This exclusive Healio resource provides you a comprehensive window into what your colleagues and key opinion leaders are saying about current and future drugs and devices and their impact on patient outcomes.
Related story »
View past polls »
Search Healio's robust listing of national and international medical meetings.
©2015 All Rights Reserved.